Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / Febru ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.
NHS England has appealed for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) which can lead to serious complications in some. It is sending ...
Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...
MANILA, Philippines — Health professionals are working to raise awareness about Respiratory Syncytial Virus (RSV), a common contagious virus that usually causes mild to severe symptoms ...
Add videos to your saved list and come back to them any time.
LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...
A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results